Core First Bank & Trust Baxter International Inc Transaction History

Core First Bank & Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$37.88 - $43.77 $83,676 - $96,687	-2,209 Reduced 67.78%	1,050 $44,000
Q3 2023 Dec 18, 2023	SELL	$37.32 - $49.29 $2,873 - $3,795	-77 Reduced 2.31%	3,259 $122,000
Q2 2023 Aug 07, 2023	SELL	$39.98 - $47.68 $18,990 - $22,648	-475 Reduced 12.46%	3,336 $151,000
Q1 2023 May 15, 2023	SELL	$37.58 - $52.57 $43,818 - $61,296	-1,166 Reduced 23.43%	3,811 $154,000
Q4 2022 Feb 15, 2023	BUY	$49.7 - $57.71 $47,264 - $54,882	951 Added 23.62%	4,977 $253,000
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $3,393 - $3,846	-46 Reduced 1.13%	4,026 $324,000
Q1 2021 May 18, 2021	SELL	$76.38 - $86.03 $15,276 - $17,206	-200 Reduced 4.68%	4,072 $343,000
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $322,066 - $351,841	4,272 New	4,272 $343,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Core First Bank & Trust with notifications on news.